Home › Funds › Royce & Associates › SLNO

Royce & Associates position in SLNO

SOLENO THERAPEUTICS INC

Latest position (Q4 2025)129.04K sh
Reported value held$5.97M
Portfolio Weight0.06%
First reportedQ1 2025
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q1 2025 4.00K $285.80K New
Q2 2025 100.70K $8.44M Add
Q3 2025 30.99K $2.09M Reduce
Q4 2025 129.04K $5.97M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding SLNO

All SLNO fund holders →